Cargando…

Effectiveness of Netarsudil as an Additional Therapy for Glaucoma in Patients Already on Maximally Tolerated Medical Therapy

PURPOSE: This study seeks to evaluate the effectiveness of netarsudil (Rhopressa) in patients with inadequately controlled IOP on otherwise maximally tolerated medical therapy. METHODS: This is a retrospective study of patients started on netarsudil at Stanford University. Exclusion criteria include...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villegas, Natacha C, Lee, Wen-Shin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572117/ https://www.ncbi.nlm.nih.gov/pubmed/34754176 http://dx.doi.org/10.2147/OPTH.S337105

Ejemplares similares

Effectiveness of Netarsudil versus Brimonidine in Eyes already Being Treated with Glaucoma Medications at a Single Academic Tertiary Care Practice: A Comparative Study
por: Pham, Alex T., et al.
Publicado: (2022)

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
por: Lin, Cheng-Wen, et al.
Publicado: (2018)

A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
por: Peace, James H., et al.
Publicado: (2020)

Netarsudil-Induced Corneal Flattening in a Child with Secondary Open-Angle Glaucoma
por: Ganesh, Durga, et al.
Publicado: (2022)

Netarsudil as an Adjunctive Therapy: Efficacy and Factors Contributing to a Favorable IOP-Lowering Effect
por: Samuel, Sandy, et al.
Publicado: (2022)

Netarsudil-associated epithelial keratopathy
por: Ramakrishnan, Meera S., et al.
Publicado: (2020)

Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date
por: Dasso, Lily, et al.
Publicado: (2018)

Netarsudil-associated reticular corneal epithelial edema
por: Tran, Jennifer A., et al.
Publicado: (2022)

A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension
por: Wang, Tao, et al.
Publicado: (2022)

Reticular corneal epithelial edema with topical netarsudil
por: Parmar, Dipali P., et al.
Publicado: (2023)

Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
por: Singh, Inder P., et al.
Publicado: (2020)

Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis
por: Lee, Jong-Wook, et al.
Publicado: (2022)

A Case Report Illustrating the Postoperative Course of Descemetorhexis without Endothelial Keratoplasty with Topical Netarsudil Therapy
por: Ploysangam, Pimpiroon, et al.
Publicado: (2019)

Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
por: Araie, Makoto, et al.
Publicado: (2021)

Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
por: Mathur, Manoj Chandra, et al.
Publicado: (2023)

Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
por: Naik, Mayuresh, et al.
Publicado: (2021)

Two pediatric cases of reticular corneal epithelial edema associated with netarsudil
por: Guzman Aparicio, Maria A., et al.
Publicado: (2022)

Short-Term Effects of Acupuncture on Open-Angle Glaucoma in Retrobulbar Circulation: Additional Therapy to Standard Medication
por: Takayama, Shin, et al.
Publicado: (2011)

The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
por: Kazemi, Arash, et al.
Publicado: (2018)

Already!
Publicado: (1892)

Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
por: Ren, Ruiyi, et al.
Publicado: (2016)

“Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost”
por: Chung, David, et al.
Publicado: (2022)

Dose-dependent effects of netarsudil, a Rho-kinase inhibitor, on the distal outflow tract
por: Chen, Si, et al.
Publicado: (2020)

The pathology behind glaucoma: what we already know using omics technologies
por: May, Caroline, et al.
Publicado: (2023)

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2
por: Asrani, Sanjay, et al.
Publicado: (2020)

100 Already?
por: Negrin, Robert S.
Publicado: (2021)

Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV
por: Bennett, Matthew T, et al.
Publicado: (2007)

Comparison of Treatment Outcomes of Selective Laser Trabeculoplasty for Primary Open-Angle Glaucoma and Pseudophakic Primary Angle-Closure Glaucoma Receiving Maximal Medical Therapy
por: Chang, Pei-Yao, et al.
Publicado: (2021)

Real-World Clinical Impact of Netarsudil 0.02% at an Urban Safety-Net Hospital
por: Fridman, Gabrielle, et al.
Publicado: (2021)

Anterior segment optical coherence tomography features of netarsudil-associated reticular corneal edema
por: Khalili, Ashley, et al.
Publicado: (2022)

Maximal Fat Oxidation During Exercise Is Already Impaired in Pre-pubescent Children With Type 1 Diabetes Mellitus
por: Fel, Solenne, et al.
Publicado: (2021)

The Booster is five already!
Publicado: (1977)

Visit the LHC... already!
Publicado: (2002)

Comparison of hemoglobin A1c goal achievement with the addition of pioglitazone to maximal/highest tolerated doses of sulfonylurea and metformin combination therapy
por: McFarland, M. Shawn, et al.
Publicado: (2012)

Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
por: Wisely, C. Ellis, et al.
Publicado: (2020)

Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials
por: Luo, Nachuan, et al.
Publicado: (2022)

Lung gene therapy—How to capture illumination from the light already present in the tunnel
por: Xia, Emily, et al.
Publicado: (2014)

Ascending aorta thrombosis in a patient with COVID-19 who was already receiving anticoagulation therapy
por: Bouratzis, Vasileios, et al.
Publicado: (2023)

Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Effects of Netarsudil on Actin-Driven Cellular Functions in Normal and Glaucomatous Trabecular Meshwork Cells: A Live Imaging Study
por: Keller, Kate E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cri2iitt8eonlnpq3dce4v8rht